Also found in: Medical.
HbA1cGlycated Haemoglobin
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
[9] Glycosylated haemoglobin (HbA1c) provides a measure of average blood glucose levels during a period of 8-12 weeks (2-3 months).
Patients treated with TTP399 showed a statistically significant mean reduction in HbA1c of 0.6% at 12 weeks, while the group treated with placebo showed a mean increase in HbA1c of 0.1%, resulting in a mean difference of 0.7% in the TTP399 group relative to the placebo group (p=0.03).
HbA1c is the product of glycation reaction of glucose and amidogen of hemoglobin under non-enzymatic catalysis, which can used as an important index reflecting glycometabolism capability.
Blood samples from them were taken in physiology department and investigated for fasting blood sugar (FBS), postprandial blood sugar (PPBS), HbA1c, and MPV (from complete blood count [CBC]).
[5] have previously shown in SA that HbA1c results were comparable to standard laboratory testing when using the DCA Vantage POCT device.
HbA1c is a hemoglobin-glucose combination formed nonenzymatically within the cell that reflects the average blood glucose level over the preceding 60-90 days.
To address these limitations and provide a broader indication of long-term glycemic control, HbA1c testing is used.
Glycated hemoglobin (also termed as HbA1c and sometimes just A1c) has been introduced lately to the physician's arsenal to monitor the diabetic control among patients.
Also, 14 mg oral semaglutide achieved a statistically significantly greater reduction in HbA1c compared to a reduction of 1.4% with Victoza.